nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

03.09.2020 | COVID-19 | Editorial Zur Zeit gratis

Anticipating the long-term cardiovascular effects of COVID-19

verfasst von: Richard C. Becker

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Excerpt

SARS-CoV2 infection can impact all organs structurally and functionally. Persisting symptoms in patients recovering from coronavirus disease 2019 (COVID-19) are common and with close follow-up can be detected in nearly 90% of patients 60 days from the original diagnosis [1]. The most common symptoms are fatigue, dyspnea, joint pain, chest pain, cough, insomnia and headache. Given the well-documented involvement of the circulatory system in COVID-19, including small, moderate and large-sized veins and arteries, coupled with robust immune and resulting local and systemic inflammatory responses, one would anticipate a prolonged recovery period and potentially long-term cardiovascular effects. The following editorial review summarizes the pathogenesis of structural, functional and metabolic abnormalities associated with COVID-19 and postulates long-term cardiovascular effects and management strategies under a broad clinical umbrella referred to as post-COVID-19 syndrome. …

Carfì A, Bernabei R, Landi F (2020) Persistent symptoms in patients after acute COVID-19. JAMA 324:603–605PubMedCrossRefPubMedCentral

Becker RC (2020) Toward understanding the 2019 Coronavirus and its impact on the heart. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-020-02107-6PubMedPubMedCentralCrossRef

Wichmann D, Sperhake JP, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder AS, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen HR, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo MM, Aepfelbacher M, Püschel K, Kluge S (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 173:268–277PubMedCrossRef

Bompard F, Monnier H, Saab I, Tordjman M, Abdoul H, Fournier L, Sanchez O, Lorut C, Chassagnon G, Revel M-P (2020) Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J 56:2001365PubMedPubMedCentralCrossRef

Patell R, Bogue T, Koshy AG, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI (2020) Post-discharge thrombosis and hemorrhage in patients with COVID-19. Blood. https://doi.org/10.1182/blood.2020007938PubMedCrossRefPubMedCentral

Patell R, Bogue T, Bindal P, Koshy A, Merrill M, Aird WC, Bauer KA, Zwicker JI (2020) Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19. J Thromb Haemost. https://doi.org/10.1111/jth.15018PubMedPubMedCentralCrossRef

Paulino M, Dumas-Diniz R, Brissos S, Brites R, Alho L, Simões MR, Silva CF (2020) COVID-19 in Portugal: exploring the immediate psychological impact on the general population. Psychol Health Med. https://doi.org/10.1080/13548506.2020.1808236PubMedCrossRef

Ebinger JE, Achamallah N, Ji H, Claggett BL, Sun N, Botting P, Nguyen TT, Luong E, Kim EH, Park E, Liu Y, Rosenberry R, Matusov Y, Zhao S, Pedraza I, Zaman T, Thompson M, Raedschelders K, Berg AH, Grein JD, Noble PW, Chugh SS, Bairey Merz CN, Marbán E, Van Eyk JE, Solomon SD, Albert CM, Chen P, Cheng S (2020) Pre-existing traits associated with Covid-19 illness severity. PLoS ONE 15:e0236240PubMedPubMedCentralCrossRef

Razzaghi H, Wang Y, Lu H, Marshall KE, Dowling NF, Paz-Bailey G, Twentyman ER, Peacock G, Greenlund KJ (2020) Estimated county-level prevalence of selected underlying medical conditions associated with increased risk for severe COVID-19 illness–United States, 2018. MMWR Morb Mortal Wkly Rep 69:945–950PubMedPubMedCentralCrossRef

10.

DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA (2019) Assessment and treatment of patients with Type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation 140:1661–1678PubMedPubMedCentralCrossRef

11.

Becker RC (2020) COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 50:54–67PubMedPubMedCentralCrossRef

12.

Jain SS, Liu Q, Raikhelkar J, Fried J, Elias P, Poterucha TJ, DeFilippis EM, Rosenblum H, Wang EY, Redfors B, Clerkin K, Griffin JM, Wan EY, Abdalla M, Bello NA, Hahn RT, Shimbo D, Weiner SD, Kirtane AJ, Kodali SK, Burkhoff D, Rabbani LE, Schwartz A, Leon MB, Homma S, Di Tullio MR, Sayer G, Uriel N, Anstey DE (2020) Indications for and findings on transthoracic echocardiography in COVID-19. J Am Soc Echocardiogr. https://doi.org/10.1016/j.echo.2020.06.009PubMedPubMedCentralCrossRef

13.

Mall G, Klingel K, Albrecht M, Seemann M, Rieger P, Kandolf R (1991) Natural history of coxsackievirus B3-induced myocarditis in ACA/Sn mice: viral persistence demonstrated by quantitative in situ hybridization histochemistry. Eur Heart J 12:121–123PubMedCrossRef

14.

Pollack A, Kontorovich AR, Fuster V, Dec GW (2015) Viral myocarditis–diagnosis, treatment options, and current controversies. Nat Rev Cardiol 12:670–680PubMedCrossRef

15.

Bültmann BD, Sotlar K, Klingel K (2004) Parvovirus B19. N Engl J Med 350:2006–2007PubMedCrossRef

16.

Lasrado N, Yalaka B, Reddy J (2020) Triggers of inflammatory heart disease. Front Cell Dev Biol 8:192PubMedPubMedCentralCrossRef

17.

Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19:80–94PubMedPubMedCentralCrossRef

18.

Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner K, Scherschel K, Kirchhof P, Escher F, Schultheiss H-P, Blankenberg S, Püschel K, Westermann D (2020) Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.3551PubMedCrossRefPubMedCentral

19.

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E (2020) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.3557PubMedPubMedCentralCrossRef

20.

Herskowitz A, Campbell S, Deckers J, Kasper EK, Boehmer J, Hadian D, Neumann DA, Baughman KL (1993) Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy. Am J Cardiol 71:982–986PubMedCrossRef

21.

Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, Cooper LT Jr, Link MS, Maron MS (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3—hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis—a scientific statement from the American heart association and American college of cardiology. Circulation 132:e273–e280PubMed

22.

Phelan D, Kim JH, Chung EH (2020) A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.2136PubMedCrossRef

23.

Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98:219–227PubMedPubMedCentralCrossRef

24.

Peleg Y, Kudose S, D'Agati V, Siddall E, Ahmad S, Kisselev S, Gharavi A, Canetta P (2020) Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep 5:940–945CrossRefPubMedPubMedCentral

25.

Farouk SS, Fiaccadori E, Cravedi P, Campbell KN (2020) COVID-19 and the kidney: what we think we know so far and what we don't. J Nephrol. https://doi.org/10.1007/s40620-020-00789-yPubMedPubMedCentralCrossRef

26.

Yap SC, Lee HT (2012) Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology 116:1139–1148PubMedCrossRef

27.

Vergaro G, Prud’homme M, Fazal L, Merval R, Passino C, Emdin M, Samuel J-L, Solal AC and Delcayre C. (2016) Inhibition of galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice. Hypertension 67:606–612PubMedCrossRef

28.

Di Lullo L, Reeves PB, Bellasi A, Ronco C (2019) Cardiorenal syndrome in acute kidney injury. Semin Nephrol 39:31–40PubMedCrossRef

29.

Chen B, Frangogiannis NG (2020) Chemokines in myocardial infarction. J cardiovasc Transl Res. https://doi.org/10.1007/s12265-020-10006-7PubMedCrossRefPubMedCentral

30.

Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539PubMedCrossRef

31.

Ikizler TA, Parikh CR, Himmelfarb J, Chinchilli VM, Liu KD, Coca SG, Garg AX, Hsu CY, Siew ED, Wurfel MM, Ware LB, Faulkner GB, Tan TC, Kaufman JS, Kimmel PL, Go AS (2020) A prospective cohort study that examined acute kidney injury and kidney outcomes, cardiovascular events and death informs on long-term clinical outcomes. Kidney Int. https://doi.org/10.1016/j.kint.2020.06.032PubMedPubMedCentralCrossRef

32.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet. https://doi.org/10.1016/S0140-6736(20)30937-5PubMedPubMedCentralCrossRef

33.

Sharma A, Garcia G, Arumugaswami V, Svendsen CN (2020) Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell Rep Med. https://doi.org/10.1016/j.xcrm.2020.100052PubMedPubMedCentralCrossRef

34.

Chatterjee V, Yang X, Ma Y, Cha B, Meegan JE, Wu M, Yuan SY (2019) Endothelial microvesicles carrying Src-rich cargo impair adherens junction integrity and cytoskeleton homeostasis. Cardiovasc Res. https://doi.org/10.1093/cvr/cvz238PubMedCentralCrossRef

35.

Robles-Cabrera A, Michel-Chávez A, Callejas-Rojas RC, Malamud-Kessler C, Delgado G, Estañol-Vidal B (2014) The cardiovagal, cardiosympathetic and vasosympathetic arterial baroreflexes and the neural control of short-term blood pressure. Revista de Neurologia. 59:508–516PubMedCrossRef

36.

Kirchheim HR (1976) Systemic arterial baroreceptor reflexes. Physiol Rev 56:100–177PubMedCrossRef

37.

Pennisi M, Lanza G, Falzone L, Fisicaro F, Ferri R, Bella R (2020) SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms. Int J Mol Sci. https://doi.org/10.3390/ijms21155475PubMedPubMedCentralCrossRef

38.

Ayres JS (2020) Surviving COVID-19: a disease tolerance perspective. Sci Adv. https://doi.org/10.1126/sciadv.abc1518PubMedPubMedCentralCrossRef

39.

Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, Hippenstiel S, Dingeldey M, Kruse B, Fauchere F, Baysal E, Mangold M, Henze L, Lauster R, Mall MA, Beyer K, Röhmel J, Voigt S, Schmitz J, Miltenyi S, Demuth I, Müller MA, Hocke A, Witzenrath M, Suttorp N, Kern F, Reimer U, Wenschuh H, Drosten C, Corman VM, Giesecke-Thiel C, Sander LE, Thiel A (2020) SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. https://doi.org/10.1038/s41586-020-2598-9PubMedCrossRefPubMedCentral

40.

Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y (2020) COVID-19: immunopathogenesis and immunotherapeutics. Sig Transduct Target Ther 5:128CrossRef

41.

Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, Liu X, Xie L, Li J, Ye J, Dong L, Cui X, Miao Y, Wang D, Dong J, Xiao C, Chen W, Wang H (2020) Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing. Cell Discov 6:31PubMedPubMedCentralCrossRef

42.

Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, Debnath O, Thürmann L, Kurth F, Völker MT, Kazmierski J, Timmermann B, Twardziok S, Schneider S, Machleidt F, Müller-Redetzky H, Maier M, Krannich A, Schmidt S, Balzer F, Liebig J, Loske J, Suttorp N, Eils J, Ishaque N, Liebert UG, von Kalle C, Hocke A, Witzenrath M, Goffinet C, Drosten C, Laudi S, Lehmann I, Conrad C, Sander L-E, Eils R (2020) COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis. Nat Biotechnol 38:970–979PubMedCrossRef

43.

Ayres JS (2020) A metabolic handbook for the COVID-19 pandemic. Nat Metab 2:572–585PubMedCrossRefPubMedCentral

44.

Kass DA, Duggal P, Cingolani O (2020) Obesity could shift severe COVID-19 disease to younger ages. Lancet 395:1544–1545PubMedPubMedCentralCrossRef

45.

Ali M, Girgis S, Hassan A, Rudick S, Becker RC (2018) Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Coron Artery Dis 29:429–437PubMedCrossRef

46.

D'Marco L, Puchades MJ, Romero-Parra M, Gimenez-Civera E, Soler MJ, Ortiz A, Gorriz JL (2020) Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J 13:297–306PubMedPubMedCentral

47.

Yang J, Brody EN, Murthy AC, Mehler RE, Weiss SJ, DeLisle RK, Ostroff R, Williams SA, Ganz P (2020) Impact of kidney function on the blood proteome and on protein cardiovascular risk biomarkers in patients with stable coronary heart disease. J Am Heart Assoc 9:e016463PubMedPubMedCentral

48.

Wang CH, Liu CY, Wan YL, Chou CL, Huang KH, Lin HC, Lin SM, Lin TY, Chung KF, Kuo HP (2005) Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS. Respir Res 6:42PubMedPubMedCentralCrossRef

49.

Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. https://doi.org/10.1001/jama.2020.2648PubMedPubMedCentralCrossRef

50.

Sasannejad C, Ely EW, Lahiri S (2019) Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care 23:352PubMedPubMedCentralCrossRef

51.

Song JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, Chua GH, Zhang C, Meng FP, Xu Z, Fu JL, Huang L, Xia P, Yang T, Zhang S, Li B, Jiang TJ, Wang R, Wang Z, Shi M, Zhang JY, Wang FS, Shui G (2020) Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab 32(188–202):e5

52.

Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. https://doi.org/10.1056/NEJMoa2015432PubMedCrossRefPubMedCentral

53.

Pundi K, Perino AC, Harrington RA, Krumholz HM, Turakhia MP (2020) Characteristics and strength of evidence of COVID-19 studies registered on ClinicalTrials.gov. JAMA Internl Med. https://doi.org/10.1001/jamainternmed.2020.2904CrossRef

54.

Ebinger JE (2020) Estimated County-Level Prevalence of Selected Underlying Medical Conditions Associated with Increased Risk for Severe COVID-19 Illness–United States, 2018. MMWR Morb Mortal Wkly Rep. 69:945–950CrossRef

Titel: Anticipating the long-term cardiovascular effects of COVID-19
verfasst von: Richard C. Becker
Publikationsdatum: 03.09.2020
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 3/2020
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02266-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Clinical features and efficacy of reperfusion therapy in minor ischemic stroke patients with atrial fibrillation

National trends in tranexamic acid use in the peripartum period, 2015–2019

Intensified P2Y12 inhibition for high-on treatment platelet reactivity

Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation

The management of patients with acute ischemic stroke while on direct oral anticoagulants (DOACs): data from an Italian cohort and a proposed algorithm